Physician profile
Bridget Eileen Oare
NPI 1619626926
$3,340.13
in general payments reported to CMS, 2019-2025
23 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $355 · 2023: $697 · 2024: $1,190 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,985.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $490.65 | 2022-2025 | |
| Abbvie INC. | $451.54 | 2023-2025 | |
| Pfizer INC. | $364.32 | 2022-2025 | |
| Incyte Corporation | $296.62 | 2022-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $244.70 | 2023 | Sotyktu |
| Galderma Laboratories, L.P. | $214.67 | 2024-2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.25 | 2022-2025 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $145.98 | 2024-2025 | Dupixent |
| Amgen INC. | $136.55 | 2022-2024 | Otezla |
| Atricure, INC. | $133.10 | 2023 | |
| Ucb, INC. | $125.00 | 2022-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $100.02 | 2023-2025 | |
| Allergan, INC. | $99.79 | 2022 | |
| Arcutis Biotherapeutics, INC. | $63.17 | 2025 | Zoryve |
| Dermavant Sciences, INC. | $61.24 | 2023-2024 | Vtama |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $47.74 | 2025 | Tremfya |
| Organon LLC | $44.82 | 2025 | |
| Leo Pharma INC. | $38.18 | 2025 | Spevigo, Anzupgo |
| Lilly USA, LLC | $24.65 | 2024 | Taltz |
| Sun Pharmaceutical Industries INC. | $18.51 | 2024 | |
| Verrica Pharmaceuticals INC. | $18.26 | 2024 | Ycanth |
| Botanix Sb INC | $14.45 | 2025 | Sofdra |
| Biofrontera INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Oare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.